Available Online: 16 Sep 2025
Current Insights into Pharmacogenomics of Noncoding RNAs for Cancer Therapy
Volume 2
GenoMed Connect facilitates interdisciplinary collaboration in advancing genomic integration into medicine. We welcome diverse contributions covering genomic medicine, translational genomics, precision medicine, human genetics, microbial genomics, technological advances, and ethical/social implications.
Time to First Peer Review Decision
Time to Final Acceptance
Acceptance to First Online
Available Online: 16 Sep 2025
Volume 2
Published: 24 Jun 2025
Volume 2
Bladder cancer remains a major global health challenge due to its high incidence, recurrence rates, and reliance on invasive diagnostic procedures. While conventional methods, such as cystoscopy and urine cytology, are considered standard, they often demonstrate limited sensitivity, particularly in detecting early-stage disease. Epigenetic alterations, particularly DNA methylation, are now recognized as critical in bladder cancer development and progression. Non-invasive..
Published: 23 Jun 2025
Volume 2
Progressive familial intrahepatic cholestasis (PFIC) is a rare group of genetic disorders that typically presents in infants and children, often progressing to end-stage liver disease. We used whole genome sequencing (WGS) for diagnosis to assess phenotypic features and outcomes in Pakistani children with different types of PFIC. The study included 116 pediatric participants with five PFIC types: PFIC1, ATP8B1 gene..
Published: 21 Apr 2025
Volume 2
Background: Oxidative stress plays a crucial role in various aspects of cancer and other diseases. While reactive oxygen species (ROS) serve as key signal molecules in physiological processes for the normal functioning of the female reproductive system, they have also been implicated in pathological processes such as polycystic ovary syndrome (PCOS). Some studies have reported a significantly higher risk of..